XML 22 R71.htm IDEA: XBRL DOCUMENT v3.2.0.727
Note 14 - Selected Quarterly Financial Data (Unaudited) - Reconciliation of Adjustments to the Previously Reported Consolidated Statements of Operations for Quarterly Information (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2015
[1]
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2014
Dec. 31, 2013
Mar. 31, 2015
Mar. 31, 2014
Mar. 31, 2013
Scenario, Previously Reported [Member]                              
Net sales   $ 8,842,000 $ 8,684,000 $ 7,442,000 $ 7,259,000 $ 7,438,000 $ 7,299,000 $ 6,909,000 $ 16,126,000 $ 14,208,000 $ 24,968,000 $ 21,646,000   $ 28,905,000 $ 27,581,000
Cost of sales   4,489,000 4,408,000 4,474,000 4,685,000 4,293,000 4,306,000 4,057,000 8,882,000 8,363,000 13,371,000 12,656,000   17,341,000 16,623,000
Gross profit   4,353,000 4,276,000 2,968,000 2,574,000 3,145,000 2,993,000 2,852,000 7,244,000 5,846,000 11,597,000 8,990,000   11,564,000 10,958,000
Income (loss) from operations   783,000 536,000 (1,139,000) (689,000) 322,000 360,000 172,000 (603,000) 533,000 180,000 854,000   165,000 2,299,000
Net income (loss)   $ 304,000 $ 188,000 $ (413,000) $ (367,000) $ 36,000 $ 106,000 $ 30,000 $ (225,000) $ 136,000 $ 79,000 $ 172,000   $ (195,000) $ 4,209,000
Net income (loss) per share - diluted (in dollars per share)   $ 0.05 $ 0.03 $ (0.08) $ (0.06) $ 0.01 $ 0.02 $ 0.01 $ (0.04) $ 0.02 $ 0.01 $ 0.03   $ (0.04) $ 0.74
Restatement Adjustment [Member]                              
Net sales   $ 849,000 $ (738,000) $ 182,000 $ (240,000) $ (37,000) $ 54,000 $ (504,000) $ (556,000) $ (450,000) $ 293,000 $ (487,000)   $ (727,000) $ (122,000)
Cost of sales   404,000 (397,000) 91,000 (132,000) (48,000) 58,000 (230,000) (306,000) (172,000) 98,000 (220,000)   (352,000) (48,000)
Gross profit   445,000 (341,000) 91,000 (108,000) 11,000 (4,000) (274,000) (250,000) (278,000) 195,000 (267,000)   (375,000) (74,000)
Income (loss) from operations   445,000 (341,000) 91,000 (108,000) 10,000 (4,000) (274,000) (250,000) (278,000) 195,000 (267,000)   (375,000) (74,000)
Net income (loss)   $ 159,000 $ (124,000) $ 32,000 $ (153,000) $ 64,000 $ (1,000) $ (135,000) $ (92,000) $ (136,000) $ 68,000 $ (72,000)   $ (225,000) $ (45,000)
Net income (loss) per share - diluted (in dollars per share)   $ 0.03 $ (0.02) $ 0.01 $ (0.03) $ 0.01 $ 0 $ (0.03) $ (0.02) $ (0.02) $ 0.02 $ (0.01)   $ (0.04) $ 0
Net sales $ 8,547,000 $ 9,691,000 [1] $ 7,946,000 $ 7,624,000 [1] $ 7,019,000 [1] $ 7,401,000 [1] $ 7,353,000 $ 6,405,000 [1] $ 15,570,000 $ 13,758,000 $ 25,261,000 $ 21,159,000 $ 33,809,000 $ 28,178,000 $ 27,459,000
Cost of sales   4,893,000 4,011,000 4,565,000 4,553,000 4,245,000 4,364,000 3,827,000 8,576,000 8,191,000 13,469,000 12,436,000 19,343,000 16,989,000 16,575,000
Gross profit 2,674,000 4,798,000 [1] 3,935,000 3,059,000 [1] 2,466,000 [1] 3,156,000 [1] 2,989,000 2,578,000 [1] 6,994,000 5,568,000 11,792,000 8,723,000 14,466,000 11,189,000 10,884,000
Income (loss) from operations   1,228,000 195,000 (1,048,000) (797,000) 332,000 356,000 (102,000) (853,000) 255,000 375,000 587,000 322,000 (210,000) 2,225,000
Net income (loss) $ (170,000) $ 463,000 [1] $ 64,000 $ (381,000) [1] $ (520,000) [1] $ 100,000 [1] $ 105,000 $ (105,000) [1] $ (317,000) $ 0 $ 147,000 $ 100,000 $ (24,000) $ (420,000) $ 4,164,000
Net income (loss) per share - diluted (in dollars per share) $ (0.03) $ 0.08 [1] $ 0.01 $ (0.07) [1] $ (0.09) [1] $ 0.02 [1] $ 0.02 $ (0.02) [1] $ (0.06) $ 0 $ 0.03 $ 0.02 $ 0 $ (0.08) $ 0.74
[1] The first, third and fourth quarters of 2015 include abnormal costs of $17,000, $196,000 and $607,000, respectively. The third and fourth quarters of 2014 include abnormal costs of $44,000 and $353,000, respectively.